Company / Cash per Share
IOVANCE BIOTHERAPEUTICS, INC. Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.53
FY2025
5-year range
$0.45 / $1455.06
FY2021-FY2025
Trend
+18.3%
vs FY2024
Sector context
#167 of 205
Health Care
What the data says
IOVANCE BIOTHERAPEUTICS, INC.'s cash per share of $0.53 is lower than 81% of companies in the Health Care sector (FY2025). Cash per Share returned to growth in FY2025 after 2 years of decline, reaching $0.53.
Based on SEC 10-K filings.
0.53 in FY2025 with a 5-year CAGR of -74.4%.
Declined from $0.61 to $0.53 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -92.8%
- 5-Year CAGR
- -74.4%
- 10-Year CAGR
- -
Sector benchmark
Bottom 19% in Health CareTop 81% of 205This company $0.53 Sector average $67.98
▼
-99.2% below sector average
Key checks
Key Insights
- In FY2025, cash per share increased 18.3% year-over-year.
- Ranks #167 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2022.
- Lowest cash per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.53 | +18.3% |
| FY2024 | $0.45 | -26.2% |
| FY2023 | $0.61 | -100.0% |
| FY2022 | $1455.06 | +185.3% |
| FY2021 | $509.95 | +4.7% |
| FY2020 | $486.83 | +333.3% |
| FY2019 | $112.35 | +9905.8% |
| FY2018 | $1.12 | -51.9% |
| FY2017 | $2.34 | +152.5% |
| FY2016 | $0.93 | +58.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026